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Giant cell arteritis followed by idiopathic
retroperitoneal fibrosis in the same
patient—an unexpected positron emission
tomography finding
A 78-year-old male patient was diagnosed with GCA, con-
firmed by positive histology of the temporal artery.
Treatment with prednisone 1 mg/kg of body weight was
initiated, tapered and stopped after 2 years. Two years
later, with unremarkable regular controls, the patient pre-
sented with lumbar pain, elevated ESR (41 mm/h) and
CRP (27 mg/l). PETCT scan (Fig. 1A) was performed,
showing moderately elevated fluoro-deoxy-glucose
(FDG) uptake in both femoral arteries and a retroperitoneal
metabolically active mass partially obstructing the left
urether. MRI scans of the abdomen (Fig. 1B) were con-
sistent with the diagnosis of idiopathic retroperitoneal fi-
brosis (IRF) with left-sided grade I hydronephrosis. IgG4
was initially elevated to 2.00 g/l (normal range 0.081.4 g/l)
subsiding to 0.62 g/l under treatment with prednisone
(1 mg/kg body weight). With 5 mg of prednisone per day,
both diseases have remained inactive for the past
6 months.
This case describes a patient suffering from both
GCA and IRF, an IgG4-related sclerosing disease often
associated with elevation of the IgG4 subclass. IRF has
not yet been described in patients with GCA. However,
similarities in histopathology with inflammation in the
medial and adventitial layers of the aorta suggest
common yet unproven pathogenetic mechanisms for IRF
and GCA.
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FIG. 1 Whole-body PET scan and MRI of the abdomen in a patient with GCA and IRF.
(A) The PET scan shows focal FDG enhancement periaortal at the level of the aortic bifurcation (difficult to discriminate
from the adjacent urether) and retention of nuclide activity due to hydronephrosis. (B) The transverse MRI of the abdomen
with gadolinium-enhanced T1-weighted, fat-saturated fast spin echo shows marked periaortic uptake of contrast ma-
terial just proximal to the aortic bifurcation.
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